Denice Torres - 03 Jan 2022 Form 4 Insider Report for Surface Oncology, Inc. (SURF)

Role
Director
Signature
/s/ Jessica Fees, Attorney-in-Fact
Issuer symbol
SURF
Transactions as of
03 Jan 2022
Transactions value $
$0
Form type
4
Filing time
05 Jan 2022, 17:00:17 UTC
Previous filing
17 Nov 2021
Next filing
06 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SURF Stock Option (Right to Buy) Award $0 +12,000 $0 12,000 03 Jan 2022 Common Stock 12,000 $5.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options shall vest in 36 equal monthly installments following December 9, 2021, so long as the grantee remains a director or other service provider of the Company on such dates.